SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 76.49 |
| Enterprise Value ($M) | 87.10 |
| Book Value ($M) | -46.26 |
| Book Value / Share | -1.27 |
| Price / Book | -1.65 |
| NCAV ($M) | -56.22 |
| NCAV / Share | -1.54 |
| Price / NCAV | -1.36 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.53 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.59 |
| Current Ratio | 0.69 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 26.17 |
| Assets | 36.13 |
| Liabilities | 82.39 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 24.38 |
| Operating Income | -24.28 |
| Net Income | -53.95 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -22.66 |
| Cash from Investing | -0.47 |
| Cash from Financing | 17.09 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | HighCape Capital, L.P. | 26.40 | 4.57 | |
| 13G/A | Silverarc Capital Management, Llc | 5.90 | 8.29 | |
| 13G/A | Hirschman Orin | 9.90 | 62.98 | |
| 13G/A | Nantahala Capital Management, LLC | 9.99 | 55.98 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 10,387 | 25,050 | 41.47 | |
| 5,073 | 29,476 | 17.21 | |
| 4,600 | 20,942 | 21.97 | |
| 14,642 | 41,370 | 35.39 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ELDN – Eledon Pharmaceuticals, Inc. | ELEV – Elevation Oncology, Inc. |
| ELTX – Elicio Therapeutics, Inc. | ENLV – Enlivex Therapeutics Ltd. |
| ENSC – Ensysce Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io